Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival
2011

Bim and Mcl-1 in JAK2V617F Cell Survival

publication Evidence: moderate

Author Information

Author(s): Rubert Joƫlle, Qian Zhiyan, Andraos Rita, Guthy Daniel A, Radimerski Thomas

Primary Institution: Novartis Institutes for BioMedical Research, Basel, Switzerland

Hypothesis

What roles do Bim and Mcl-1 play in regulating the survival of JAK2V617F mutant cells?

Conclusion

Bim and Mcl-1 have opposing roles in regulating JAK2V617F cell survival, and targeting both may enhance treatment efficacy.

Supporting Evidence

  • Bim activation was triggered by JAK2 inhibition, leading to increased cell death.
  • Depletion of Mcl-1 compromised cell viability and sensitized cells to JAK2 inhibition.
  • Bim depletion suppressed JAK2 inhibitor-induced apoptosis in both SET-2 and MB-02 cells.
  • JAK2 inhibition resulted in a drop in Mcl-1 levels and changes in Bim phosphorylation.

Takeaway

This study found that two proteins, Bim and Mcl-1, help decide if certain cancer cells live or die, and changing their levels could help treat the cancer better.

Methodology

The study used pharmacological inhibition, Western blot analysis, WST-1 proliferation assays, and flow cytometry to assess cell survival and apoptosis.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-11-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication